Effect of Shenqi Fuzheng Injection in Improving Sensitivity of Human Breast Cancer MDA-MB-231 Cells to Cisplatin Through Tumor Associated Macrophages

Qian-mei ZHOU; Shi-bing SU

doi:10.13422/j.cnki.syfjx.20200421

您当前的位置：

首页 >

文章列表页 >

Effect of Shenqi Fuzheng Injection in Improving Sensitivity of Human Breast Cancer MDA-MB-231 Cells to Cisplatin Through Tumor Associated Macrophages

Pharmacology | 更新时间：2021-02-09

- Effect of Shenqi Fuzheng Injection in Improving Sensitivity of Human Breast Cancer MDA-MB-231 Cells to Cisplatin Through Tumor Associated Macrophages
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 4, Pages: 76-81(2020)
- 作者机构：
  
  上海中医药大学，上海　 201203
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200421
  CLC： R22; R242; R2-031;R285.5
- Received：10 May 2019，
  
  Published Online：04 November 2019，
  
  Published：20 February 2020
- 稿件说明：
移动端阅览
Qian-mei ZHOU, Shi-bing SU. Effect of Shenqi Fuzheng Injection in Improving Sensitivity of Human Breast Cancer MDA-MB-231 Cells to Cisplatin Through Tumor Associated Macrophages[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(4): 76-81.
DOI：

Qian-mei ZHOU, Shi-bing SU. Effect of Shenqi Fuzheng Injection in Improving Sensitivity of Human Breast Cancer MDA-MB-231 Cells to Cisplatin Through Tumor Associated Macrophages[J]. Chinese journal of experimental traditional medical formulae, 2020, 26(4): 76-81. DOI： 10.13422/j.cnki.syfjx.20200421.

摘要

目的：

观察参芪扶正注射液通过免疫调节提高顺铂化疗的敏感性，并探讨其作用机制。

方法：

采用噻唑蓝(MTT)比色法测定参芪扶正注射液1，10，100 mL·L

-1

对细胞的敏感性，流式细胞法检测细胞凋亡率，酶联免疫印迹法(Western blot)检测凋亡相关蛋白的表达，酶联免疫吸附实验(ELISA)检测细胞因子表达水平。

结果：

参芪扶正注射液能显著抑制人乳腺癌细胞MDA-MB-231与THP-1共培养细胞生长，参芪扶正注射液10，100 mL·L

-1

时，其细胞存活率分别为71.8%，59.9%；参芪扶正注射液10 mL·L

-1

与顺铂联合运用，提高了共培养细胞对顺铂的敏感性，顺铂的半数抑制浓度(IC

)由30 μmol·L

-1

降低至15 μmol·L

-1

；联合运用参芪扶正注射液10 mL·L

-1

和顺铂，比15 μmol·L

-1

顺铂诱导的细胞凋亡率增加了15.5%(

0.05)；联合用药均能明显抑制B细胞淋巴瘤-2(Bcl-2)，B细胞淋巴瘤-w(Bcl-w)和细胞外大淋巴瘤(Bcl-xl)的表达，增加Bcl-2相关X蛋白(Bax)和人BH3结构域凋亡诱导蛋白(Bid)的表达(

0.05)；参芪扶正注射液降低顺铂诱导的白细胞介素-10(IL-10)和前列腺素E

(PGE

)的释放(

0.05)。

结论：

参芪扶正注射液通过调节免疫细胞改善了乳腺癌细胞MDA-MB-231对顺铂的敏感性，起到协同抑制肿瘤细胞增殖的作用。该研究为益气扶正防治肿瘤提供实验依据，为中医药缓解肿瘤耐药研究提供实验参考。

Abstract

Objective:

To investigate the effect of Shenqi Fuzheng injection on the sensitivity of cisplatin through immunomodulation

in order to explore its mechanisms.

Method:

The cell survival was measured by thiazolyl blue tetrazolium bromide (MTT)

the rate of apoptosis was detected by flow cytometry

the expressions of apoptosis-related proteins were detected by Western blot

and the expression level of cytokines was detected by enzyme linked immunosorbent assay (ELISA).

Result:

Shenqi Fuzheng injection 1

100 mL·L

-1

significantly inhibited the growth of co-cultured cells

and the cell survival rate was 71.8%and 59.9%at the concentration of 10

100 mL·L

-1

respectively.Shenqi Fuzheng injection 10 mL·L

-1

combined with cisplatin significantly increased the sensitivity of co-cultured cells to cisplatin.The half maximal inhibitory concentration (IC

) of cisplatin was reduced from 30 to 15 μmol·L

-1

.The rate of apoptosis induced by the combined treatment increased by 15.5%compared with that of cisplatin 15 μmol·L

-1

(

0.05). The expressions of B-cell lymphoma-2 (Bcl-2)

B-cell lymphoma-w (Bcl-w) and B-cell lymphoma-extra large (Bcl-xl) were inhibited

and the expressions of Bcl-2-associated X protein (Bax) and protein induced by BH3 domain (Bid) apoptosis were increased (

0.05). Shenqi Fuzheng injection reduced the release of interleukin-10 (IL-10) and prostaglandin E

(PGE

) induced by cisplatin (

0.05).

Conclusion:

Shenqi Fuzheng injection improves the sensitivity of MDA-MB-231 to cisplatin by regulating immune cells

and plays a synergistic role in inhibiting the proliferation of breast cancer cells.This study provides experimental basis for the prevention and treatment of tumors with Yiqi Fuzheng method

and experimental reference for the study of traditional Chinese medicine in alleviating drug resistance of tumors.

关键词

Keywords

references

许家瑞，胡剑，刘冬冬，等．长链非编码RNA在乳腺癌中的研究进展 [J]．分子诊断与治疗杂志， 2018 , 10 ( 1 )： 61 - 66 .

蒋伯刚，陈林，张汉超．三阴性乳腺癌的研究进展 [J]．中国妇幼保健， 2012 , 27 ( 30 )： 4819 - 4821 .

H YAO , G HE , S YAN , et al . Triple-negative breast cancer：is there a treatment on the horizon [J]． Oncotarget , 2017 , 8 ( 1 )： 1913 - 1924 .

洪锐东．参芪扶正注射液联合化疗治疗晚期三阴性乳腺癌的效果 [J]．北方药学， 2015 , 12 ( 6 )： 25 - 26 .

张强，蔡军波，陈鑫，等．参芪扶正注射液联合化疗治疗晚期三阴性乳腺癌32例 [J]．中国药师， 2013 , 16 ( 12 )： 1866 - 1867 .

刘小英，宋小玲．参芪扶正注射液辅助治疗乳腺癌对患者免疫功能及生活质量的影响 [J]．上海医药， 2017 , 38 ( 19 )： 29 - 31，37 .

佘青，张锦，李有怀，等．参芪扶正注射液用于乳腺癌根治术后辅助化疗的临床效果观察 [J]．广西医科大学学报， 2017 , 34 ( 12 )： 1734 - 1737 .

钟陆行，熊建萍，张锡泉．参芪扶正注射液对K562/ADM多药耐药的影响 [J]．江西医学院学报， 2006 , 46 ( 4 )： 41 - 44 .

朱玉芬，李崖青，付丽．肿瘤相关巨噬细胞与乳腺癌关系的研究进展 [J]．天津医科大学学报， 2014 , 20 ( 6 )： 499 - 501，505 .

杜江洋，徐元，王楠，等．白花蛇舌草-半枝莲药对组分诱导三阴性乳腺癌细胞凋亡的机制 [J]．中国实验方剂学杂志， 2018 , 24 ( 17 )： 99 - 107 .

李云祥，梁引库，高飞雄，等．中药治疗乳腺癌疾病研究进展 [J]．中国实验方剂学杂志， 2019 , 25 ( 3 )： 211 - 219 .

文柳静，王晨，任丽．参芪扶正注射液对胰腺癌多药耐药逆转作用研究 [J]．中国药学杂志， 2017 , 52 ( 13 )： 1147 - 1151 .

熊英，刘春英，王淳．参芪扶正注射液对人肺腺癌耐药细胞株A549/DDP的增敏作用 [J]．上海中医药大学学报， 2016 , 30 ( 4 )： 52 - 56 .

D Merino , S W Lok , J E Visvader , et al . Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer [J]． Oncogene , 2016 , 35 ( 15 )： 1877 - 1887 .

刘晓菲，李静蔚，时光喜，等．温阳散结中药干预乳腺癌细胞SK-BR-3的生长抑制及诱导凋亡研究 [J]．中国医药导报， 2018 , 15 ( 2 )： 13 - 18 .

黄器伟，翟娜娜，黄涛，等．毛钩藤碱通过线粒体途径诱导乳腺癌MDA-MB-231细胞凋亡 [J]．生理学报， 2018 , 70 ( 1 )： 40 - 46 .

Q M ZHOU , X F WANG , X J LIU , et al . Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects [J]． Eur J Cancer , 2011 , 47 ( 14 )： 2240 - 2247 .

Q M ZHOU , Y SUN , Y Y LU , al at . Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis [J]． Cancer Cell Int , 2017 , 17 ( 1 )： 84 .

P Allavena , A Sica , C Garlanda , et al . The Yin-Yang of tumor-associated macrophages in neoplasticprogression and immune surveillance [J]． Immunol Rev , 2008 , 222 ( 1 )： 155 - 161 .

T Hagemann , T Lawrence , I McNeish , et al . ”Reeducating” tumor-associated macrophages by targeting NF-kappa B [J]. J Exp Med , 2008 , 205 ( 6 )： 1261 - 1268 .

梅龙，董晓慧，段刚，等．参芪注射液对H22荷瘤小鼠抑瘤作用的细胞免疫机制 [J]．西安交通大学学报：医学版， 2007 , 28 ( 3 )： 279 - 282 .

廖修用，刘忠和，余灏东，等．参芪扶正注射液联合化疗对胃癌患者外周血细胞水平、肿瘤标志物及免疫功能的影响 [J]．海南医学院学报， 2018 ， 24 ( 2 )： 181 - 184 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Aloe Emodin Alone and in Combination with Cisplatin on Cell Proliferation and Apoptosis of Breast Cancer Cell Line MDA-MB-231

Exploring Mechanism of Breast Cancer Prevention by Liuwei Dihuangwan， Erzhiwan and Zuoguiwan Based on Macrophage Phagocytosis

Screening of Anti-breast Cancer Active Ingredients in Famous Classical Formula Yanghetang

Intervention of Breast Cancer by Regulating Wnt/β-catenin Signaling Pathway with Traditional Chinese Medicine： A Review

Role and Mechanism of Cucurbitacin B in Suppressing Proliferation of Breast Cancer 4T1 Cells via Inducing Ferroptosis

Related Author

TAO Yi-ming

HONG Xue

MA Yi-li

LIAO Chao-liang

ZHENG Lixiang

CHEN Yishan

QUAN Wei

ZHONG Youbao

Related Institution

Jiangxi University of Chinese Medicine

Dongfang Hospital， Beijing University of Chinese Medicine

The First Clinical Medical College of Heilongjiang University of Traditional Chinese Medicine （TCM）

The First Affiliated Hospital of Heilongjiang University of TCM

School of Chinese Material Medica， Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰